Business AstraZeneca reinforces oncology leadership at ESMO Asia 2024 with pivotal data in lung, GI and breast cancersBy Team OrangeJanuary 11, 20250 AstraZeneca continues to advance its ambition to revolutionise cancer care with pivotal data presented for lung, gastrointestinal (GI), and breast…
